TNSN99211A1 - Derives d'hygromycine a nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. - Google Patents
Derives d'hygromycine a nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.Info
- Publication number
- TNSN99211A1 TNSN99211A1 TNTNSN99211A TNSN99211A TNSN99211A1 TN SN99211 A1 TNSN99211 A1 TN SN99211A1 TN TNSN99211 A TNTNSN99211 A TN TNSN99211A TN SN99211 A TNSN99211 A TN SN99211A TN SN99211 A1 TNSN99211 A1 TN SN99211A1
- Authority
- TN
- Tunisia
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- novel
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
L'INVENTION CONCERNE DES COMPOSES DE FORMULE 1 : DANS LAQUELLE R1, R2, R3, X1 ET X2 REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT UN PROCEDE POUR LEUR PREPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITONS POUR LE TRAITEMENT DE DIVERSES INFECTIONS BACTERIENNES ET INFECTIONS PAR DES PROTOZOAIRES ET D'AFFECTIONS LIEES A CES INFECTIONS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11061898P | 1998-12-02 | 1998-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN99211A1 true TNSN99211A1 (fr) | 2005-11-10 |
Family
ID=22334003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN99211A TNSN99211A1 (fr) | 1998-12-02 | 1999-11-10 | Derives d'hygromycine a nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US6245745B1 (fr) |
| EP (1) | EP1135400A1 (fr) |
| JP (1) | JP3393189B2 (fr) |
| KR (1) | KR100418167B1 (fr) |
| CN (1) | CN1329617A (fr) |
| AP (1) | AP2001002154A0 (fr) |
| AR (1) | AR019784A1 (fr) |
| AU (1) | AU6362799A (fr) |
| BG (1) | BG105645A (fr) |
| BR (1) | BR9915813A (fr) |
| CA (1) | CA2352332C (fr) |
| CO (1) | CO5150171A1 (fr) |
| CZ (1) | CZ20011904A3 (fr) |
| DZ (1) | DZ2932A1 (fr) |
| EA (1) | EA004303B1 (fr) |
| EE (1) | EE200100301A (fr) |
| GE (1) | GEP20033144B (fr) |
| GT (1) | GT199900205A (fr) |
| HN (1) | HN1999000202A (fr) |
| HR (1) | HRP20010413A2 (fr) |
| HU (1) | HUP0104949A3 (fr) |
| ID (1) | ID28848A (fr) |
| IL (1) | IL142882A0 (fr) |
| IS (1) | IS5930A (fr) |
| MA (1) | MA26705A1 (fr) |
| NO (1) | NO20012687D0 (fr) |
| NZ (1) | NZ511424A (fr) |
| OA (1) | OA11721A (fr) |
| PA (1) | PA8486101A1 (fr) |
| PE (1) | PE20001429A1 (fr) |
| PL (1) | PL348063A1 (fr) |
| SK (1) | SK7302001A3 (fr) |
| TN (1) | TNSN99211A1 (fr) |
| TR (1) | TR200101540T2 (fr) |
| UY (1) | UY25827A1 (fr) |
| WO (1) | WO2000032616A1 (fr) |
| YU (1) | YU32601A (fr) |
| ZA (1) | ZA200104434B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL148577A0 (en) * | 1999-10-29 | 2002-09-12 | Pfizer Prod Inc | Hygromycin derivatives |
| CN1382149A (zh) * | 1999-10-29 | 2002-11-27 | 辉瑞产品公司 | 潮霉素a前药 |
| EE200200671A (et) | 2000-06-02 | 2004-08-16 | Pfizer Products Inc. | Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks |
| US20050031181A1 (en) * | 2003-06-19 | 2005-02-10 | Xiaoli Bi | Method and system for analyzing bone conditions using DICOM compliant bone radiographic image |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU755806B2 (en) * | 1998-05-04 | 2002-12-19 | Pfizer Products Inc. | Hygromycin A derivatives |
| WO1999057127A1 (fr) * | 1998-05-04 | 1999-11-11 | Pfizer Products Inc. | Derives 2 ? -desoxy-hygromycine |
-
1999
- 1999-11-09 KR KR10-2001-7006849A patent/KR100418167B1/ko not_active IP Right Cessation
- 1999-11-09 AU AU63627/99A patent/AU6362799A/en not_active Abandoned
- 1999-11-09 OA OA1200100135A patent/OA11721A/en unknown
- 1999-11-09 YU YU32601A patent/YU32601A/sh unknown
- 1999-11-09 TR TR2001/01540T patent/TR200101540T2/xx unknown
- 1999-11-09 EP EP99951055A patent/EP1135400A1/fr not_active Withdrawn
- 1999-11-09 HU HU0104949A patent/HUP0104949A3/hu unknown
- 1999-11-09 EA EA200100444A patent/EA004303B1/ru not_active IP Right Cessation
- 1999-11-09 JP JP2000585257A patent/JP3393189B2/ja not_active Expired - Fee Related
- 1999-11-09 WO PCT/IB1999/001798 patent/WO2000032616A1/fr not_active Application Discontinuation
- 1999-11-09 BR BR9915813-2A patent/BR9915813A/pt not_active IP Right Cessation
- 1999-11-09 CN CN99813939A patent/CN1329617A/zh active Pending
- 1999-11-09 CZ CZ20011904A patent/CZ20011904A3/cs unknown
- 1999-11-09 PL PL99348063A patent/PL348063A1/xx not_active Application Discontinuation
- 1999-11-09 EE EEP200100301A patent/EE200100301A/xx unknown
- 1999-11-09 SK SK730-2001A patent/SK7302001A3/sk unknown
- 1999-11-09 GE GEAP19995922A patent/GEP20033144B/en unknown
- 1999-11-09 NZ NZ511424A patent/NZ511424A/en unknown
- 1999-11-09 IL IL14288299A patent/IL142882A0/xx unknown
- 1999-11-09 AP APAP/P/2001/002154A patent/AP2001002154A0/en unknown
- 1999-11-09 ID IDW00200101182A patent/ID28848A/id unknown
- 1999-11-09 CA CA002352332A patent/CA2352332C/fr not_active Expired - Fee Related
- 1999-11-10 MA MA25843A patent/MA26705A1/fr unknown
- 1999-11-10 TN TNTNSN99211A patent/TNSN99211A1/fr unknown
- 1999-11-10 DZ DZ990232A patent/DZ2932A1/fr active
- 1999-11-15 AR ARP990105799A patent/AR019784A1/es not_active Application Discontinuation
- 1999-11-18 HN HN1999000202A patent/HN1999000202A/es unknown
- 1999-11-25 CO CO99074411A patent/CO5150171A1/es unknown
- 1999-11-29 PE PE1999001195A patent/PE20001429A1/es not_active Application Discontinuation
- 1999-11-30 PA PA19998486101A patent/PA8486101A1/es unknown
- 1999-11-30 UY UY25827A patent/UY25827A1/es unknown
- 1999-12-01 GT GT199900205A patent/GT199900205A/es unknown
- 1999-12-02 US US09/453,429 patent/US6245745B1/en not_active Expired - Fee Related
-
2001
- 2001-04-27 IS IS5930A patent/IS5930A/is unknown
- 2001-05-29 HR HR20010413A patent/HRP20010413A2/hr not_active Application Discontinuation
- 2001-05-30 ZA ZA200104434A patent/ZA200104434B/en unknown
- 2001-05-31 NO NO20012687A patent/NO20012687D0/no not_active Application Discontinuation
- 2001-06-25 BG BG105645A patent/BG105645A/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN98082A1 (fr) | DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A. | |
| TNSN98238A1 (fr) | Macrolides nouveaux | |
| TNSN99236A1 (fr) | Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN00104A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN98194A1 (fr) | Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN98084A1 (fr) | Derives de macrolides substitues en position c-4 | |
| TNSN99106A1 (fr) | Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN00007A1 (fr) | Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN99162A1 (fr) | Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN99169A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN01091A1 (fr) | Derives bicycliques nouveaux, compositions les contenant et leur utilisation pour le traitement d'une croissance cellulaire anormale | |
| TNSN96172A1 (fr) | Composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN99170A1 (fr) | Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN00028A1 (fr) | Derives de quinoleine -2-one a substituant heteroaryle nouveaux procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN98203A1 (fr) | Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant | |
| TNSN00065A1 (fr) | Derives nouveaux de pyrimidine inhibiteurs de sorbitol- deshydrogenase, leur procede de preparation et compositions pharmaceutiques les contenant. | |
| TNSN97110A1 (fr) | Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN98083A1 (fr) | Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN99156A1 (fr) | Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN00036A1 (fr) | Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN00228A1 (fr) | Derives de benzimidazole nouveaux, et compositions les contenant | |
| TNSN99142A1 (fr) | Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation. | |
| TNSN00235A1 (fr) | Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant | |
| TNSN99155A1 (fr) | 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| TNSN99031A1 (fr) | Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant |